The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $44.65

Today's change+0.61 +1.39%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.
 

Neogen Corp

Nasdaq: NEOG
Last

(U.S.) $44.65

Today's change+0.61 +1.39%
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Neogen Corp up (U.S.)$0.61

Neogen Corp closed up Wednesday by (U.S.)$0.61 or 1.39% to (U.S.)$44.65. Over the last five days, shares have gained 7.36%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 25.11% during the last year.

Key company metrics

  • Open(U.S.) $43.85
  • Previous close(U.S.) $44.04
  • High(U.S.) $44.89
  • Low(U.S.) $43.85
  • Bid / Ask-- / --
  • YTD % change-2.30%
  • Volume122,220
  • Average volume (10-day)109,972
  • Average volume (1-month)112,957
  • Average volume (3-month)134,251
  • 52-week range(U.S.) $35.50 to (U.S.) $51.22
  • Beta1.07
  • Trailing P/E57.17×
  • P/E 1 year forward47.82×
  • Forward PEG3.17×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.78
Updated November 26 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.40%

Based on its net profit margin of 11.40%, Neogen Corp is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedAug 31, 201408/31/2014May 31, 201405/31/2014Feb 28, 201402/28/2014Nov 30, 201311/30/2013
Revenue68676260
Total other revenue--------
Total revenue68676260
Gross profit34323129
Total cost of revenue34353130
Total operating expense54565250
Selling / general / administrative18191817
Research & development2222
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income13111010
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax14111010
Income after tax9876
Income tax, total5444
Net income9876
Total adjustments to net income--------
Net income before extra. items9876
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9876
Inc. avail. to common incl. extra. items9876
Diluted net income9876
Dilution adjustment--------
Diluted weighted average shares37383737
Diluted EPS excluding extraordinary itemsvalue per share0.240.200.180.17
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.240.200.180.17